Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.
| Added by | pmartino |
|---|---|
| Group name | EquipePM |
| Item Type | Attachment |
| Title | Full Text |
| URL | https://jitc.bmj.com/content/jitc/12/1/e007135.full.pdf |
| Accessed | 2024/08/02 - 11:52:59 |
| Date Added | 2024/08/02 - 09:52:59 |
| Date Modified | 2024/08/02 - 09:52:59 |
| Parent item | A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer |
Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).
U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de